Methyl morpholine oxide → HCID 86232871, compound
Reaction equation
[C:1]1([C:7]2[C:8]([CH2:27][OH:28])=[CH:9][N:10]([S:18]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=3)(=[O:20])=[O:19])[C:11]=2[C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C[N+]1([O-])CCOCC1>[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[C:1]1([C:7]2[C:8]([CH:27]=[O:28])=[CH:9][N:10]([S:18]([C:21]3[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=3)(=[O:19])=[O:20])[C:11]=2[C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Using [4,5-diphenyl-1-(phenylsulfonyl)-1H-pyrrol-3-yl]methanol (352 mg), tetra-n-propylammonium perruthenate (13.8 mg), N-methylmorpholine N-oxide (159 mg) and molecular sieves 4A powder (177 mg), a procedure as in Reference Example 6 was performed to give the title compound as white crystals (yield 250 mg, 72%).
Sources & evidence
- ORD record
- ord-bc31bbffd7d94f5bb9ec6b568a02df73
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08048909B2
Reaction notes
Loading…